11 New 4-Star Stocks This Week
Morningstar identified 11 new 4-star undervalued stocks, including ASML, Synopsys, CRH, Autodesk, and Magna International. ASML is trading at a 16% discount to its $2,050 fair value estimate, while Synopsys is at a 24% discount to its $520 estimate. The US stock market is moderately undervalued, with 33% of covered stocks undervalued.
How this was made
The 30-second read
Why it matters
The rating changes provide a fresh data point for quantitative value screens and may trigger short‑term rebalancing by funds that track Morningstar signals.
Market read
The article introduces new 4‑star ratings for five mid‑ to large‑cap stocks, offering a modest trading signal for value‑focused strategies.
What to watch
High uncertainty ratings suggest macro‑risk exposure that may outweigh the discount appeal.
Background
Morningstar’s weekly screen identifies newly undervalued stocks and updates their proprietary rating system.
Ticker impact
Morningstar upgraded ASML to a 4‑star rating, indicating it is now undervalued.
Potential modest upside as investors re‑price the discount.
ASML’s fair‑value gap and high uncertainty suggest a cautious but positive bias.
Morningstar raised Synopsys to a 4‑star rating after a price decline.
Likely short‑term buying pressure.
Discount to fair value and wide moat make the stock attractive to value investors.
Morningstar upgraded CRH to a 4‑star rating, flagging it as undervalued.
Small upside potential.
Building‑materials sector is less volatile; rating change alone is a limited catalyst.
Morningstar moved Autodesk to a 4‑star rating after a weekly loss.
Limited price movement expected.
Rating change is modest and the stock already faced a sharp decline.
Morningstar upgraded Magna International to a 4‑star rating.
Potential modest rally.
Discount to fair value and high uncertainty may attract contrarian buyers.
Market effects
Value‑oriented rating upgrades may lift other undervalued stocks in the semiconductor, software, and industrial sectors.
European‑listed firms (CRH) receive a US‑focused rating, potentially increasing cross‑border investor flow.
Limited; primarily affects individual stock valuations rather than broad market indices.
Counterpoint
Rating upgrades could be premature if underlying earnings or growth outlooks remain weak.
Key entities
- Research ProviderMorningstar
Provides proprietary stock rating methodology.
